Skip to main content

Karen D. Corbin, PhD, RD

Karen D. Corbin, PhD, RD

Investigator at the Translational Research Institute

Translational Research

Karen D. Corbin

Overview

Dr. Corbin is an Investigator at the Translational Research Institute. Her program of research focuses on enterohepatic metabolism and the mechanisms that drive individual susceptibility to metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), diabetes and obesity.

Dr. Corbin came to the TRI-MD after a 3-year term as a Research Assistant Professor at UNC Chapel Hill, Gillings School of Global Public Health, Department of Nutrition. Dr. Corbin earned her doctorate degree in molecular medicine at the University of South Florida College of Medicine in 2008. She became a registered dietitian in 1998 after completing her dietetic internship at the James A. Haley Veteran’s Hospital in Tampa, FL. She earned her Bachelor’s Degree in Nutrition and Food Science in 1997 at Florida State University.

Dr. Corbin’s research portfolio includes both investigator-initiated and industry clinical-translational studies focused on novel pathogenic mechanisms and therapeutics. Her work is highly innovative and transdisciplinary and has the potential to lead to important advances in prevention and treatment strategies for common metabolic diseases.

Articles

Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity

JOURNAL OF NUTRITION

2023

Measurement of 24-h continuous human CH4 release in a whole room indirect calorimeter

JOURNAL OF APPLIED PHYSIOLOGY

2023

Extracellular vesicle proteomics and phosphoproteomics identify pathways for increased risk in patients hospitalized with COVID-19 and type 2 diabetes mellitus

DIABETES RESEARCH AND CLINICAL PRACTICE

2023

Glucagon-like peptide-1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial

Obesity

2023

Design of the Advancing Care for Type 1 Diabetes and Obesity Network energy metabolism and sequential multiple assignment randomized trial nutrition pilot studies: An integrated approach to develop weight management solutions for individuals with type 1 d

Contemporary clinical trials

2022

Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozin

DIABETES OBESITY & METABOLISM

2022

Relationship Between Moderate-to-Vigorous Physical Activity and Glycemia Among Young Adults with Type 1 Diabetes and Overweight or Obesity: Results from the Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) Study

Diabetes technology & therapeutics

2022

Weight management in young adults with type 1 diabetes: The advancing care for type 1 diabetes and obesity network sequential multiple assignment randomized trial pilot results

DIABETES OBESITY & METABOLISM

2022

The Intestinal Microbiota and Short-Chain Fatty Acids in Association with Advanced Metrics of Glycemia and Adiposity Among Young Adults with Type 1 Diabetes and Overweight or Obesity

CURRENT DEVELOPMENTS IN NUTRITION

2022

More hypoglycemia not associated with increasing estimated adiposity in youth with type 1 diabetes

PEDIATRIC RESEARCH

2022

Education & Training

Education

University of South Florida College of Medicine

Fellowship

James A. Haley Veteran's Hospital, Tampa, FL

Associated Clinical Trials